The Inotropic Effects of UK 14,275, a Phosphodiesterase Inhibitor, in Man.

British Journal of Clinical Pharmacology- United Kingdom

doi 10.1111/j.1365-2125.1978.tb01591.x

Full Text

Abstract

Available in

Categories

Date

January 1, 1978

Authors

Publisher

Wiley

Related search

Phosphodiesterase PDE3 Blunts the Positive Inotropic and Cyclic AMP Enhancing Effects of CGP12177 but Not of Noradrenaline in Rat Ventricle

British Journal of Pharmacology

English

Effects of Cilostazol, a Selective Cyclic AMP Phosphodiesterase Inhibitor on Isolated Rabbit Spinal Arterioles.

The Japanese Journal of Physiology

English

Ab Initiostructure Determination of a New Phosphodiesterase Enzyme Inhibitor

Acta Crystallographica Section A Foundations of Crystallography

English

Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

Rheumatology and Therapy

English

Therapeutic Potential of a New Phosphodiesterase Inhibitor in Acute Lung Injury

European Respiratory Journal

Respiratory Medicine

English

Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis

Clinical Gastroenterology and Hepatology

Gastroenterology

English

Stabilities of UK, Pro-Uk and UK-UK Inhibitor Complex in Human Plasma.

English

cAMP/PKA/CREB/GLT1 Signaling Involved in the Antidepressant-Like Effects of Phosphodiesterase 4D Inhibitor (GEBR-7b) in Rats

Neuropsychiatric Disease and Treatment

English

Cancer Therapy Combination: Green Tea and a Phosphodiesterase 5 Inhibitor?

Journal of Clinical Investigation

English